-
Antu Biocarbohydrate Antigen CA15-3 Calibrator Obtained Medical Device Registration Certificate
Time of Update: 2021-09-30
On September 22, Antu Biological issued an announcement stating that the company had recently received the "Medical Device Registration Certificate" for the carbohydrate antigen CA15-3 calibrator issued by the Henan Provincial Drug Administration for use in the company's fully automated chemiluminescence detection.
-
Aotai Biology, Kaitron Biology, and Oriental Biology win the case against gabapentin immunoassay product 337 investigation
Time of Update: 2021-08-16
"Science Innovation Board Daily" reported on the 3rd, on July 1, US time, the United States International Trade Commission (ITC) made a final ruling on the investigation of gabapentin immunoassay kit
-
The National Medical Insurance Bureau opens up O2O medical insurance payment integration services, or spawns "super pharmacies
Time of Update: 2021-08-02
The "Opinions" clearly stated: Actively promote "Internet + medical services", follow the principle of online and offline fairness and medical insurance payment policies, improve protocol management and settlement procedures based on service characteristics, actively explore information sharing, and realize prescription circulation, online payment and settlement, Integrated service of home delivery of medicines .
-
Newly developed absorbable cardiac pacemakers and wearable nucleic acid biosensors
Time of Update: 2021-07-29
The author of the paper believes that the successful embedding of synthetic biological sensors in wearable fabrics is the first step to create multifunctional smart clothing, which is expected to achieve a wider range of applications such as biomedicine .
-
Waiting for 23 years of breakthrough
Time of Update: 2021-06-02
Today, AstraZeneca and Sanofi jointly announced that the research antibody nirsevimab has reached the primary endpoint in a phase 3 clinical trial, successfully preventing respiratory syncytial virus (RSV) infection in infants.
In the phase 3 clinical trial, nirsevimab reached the primary endpoint.
-
PI3K dual inhibitor
Time of Update: 2021-05-02
's Duensibu Capsules (trade name: Kebituo) has been approved by the China National Medical Products Administration ( NMPA) accepted and received conditional approval for listing and priority review qualifications.
[1]Voluntary Announcement-The National Medical Products Administration accepts the listing application of "Duensibu Capsules".
-
Eli Lilly closes Dermira plant to transfer hyperhidrosis drug Qbrexza
Time of Update: 2021-05-02
A few days ago, Eli Lilly announced that it would close its Dermira plant in Menlo Park, lay off 163 employees, and intend to sell the hyperhidrosis drug Qbrexza to Journey Medical.
-
NEJM | Pfizer Vaccine Shows Neutralizing Effect Against Three Major New Coronary Mutant Viruses
Time of Update: 2021-03-22
▲The neutralization ability of the serum of inoculated BNT162b2 volunteers against different new coronavirus mutant strains (picture source: reference [1]) In two recombinant virus strains carrying partial mutations in the spike protein of the B.
-
The State Council’s major documents may affect all pharmaceutical companies
Time of Update: 2021-02-10
From the above points of view, including strengthening drug patent protection, strengthening anti-monopoly of raw materials, pharmaceutical recruitment and implementation of credit supervision, and promote the development of Internet medical care are very important measures to promote the development of the pharmaceutical industry.
-
The medical device sector is approaching the eve of the outbreak as the country accelerates the approval of innovative devices
Time of Update: 2021-02-07
, the United States, the European Union and Japan are powerful countries in medical devices, and almost monopolize the global market for large, high-end, high-quality and innovative medical devices, said Gao Guoxuan.
-
To guide the production of shortage drugs to treat the lack of medicines for children
Time of Update: 2021-02-06
According to the Ministry of Industry and Information Technology website news, a few days ago, the Ministry of Industry and Information Technology and other six departments jointly issued the "Pharmaceutical Industry Development Planning Guide." The Guide proposes to guide enterprises to develop and produce shortage drugs, focusing on rare disease drugs, lack of children's medicine and first aid drugs, low-cost drug supply security capacity is weak.
-
A pat on the neck that's paralysed? This kind of "Japanese disease", do not press
Time of Update: 2020-10-17
" on-duty doctor introduced, due to the emergency situation, the next day Wang Yue team to lao Mao carried out C5, C6 vertebral surgery, surgery can be seen, the spinal cord of his cervical spine was bone-crushed after the ligament compression, local pressure is obvious.
-
Authoritative Answer: What are the categories of projects using water-based and UV paints in soil evaluation
Time of Update: 2020-10-07
Topic: projects using water-based and UV paint fall into several categories in soil evaluation If UV paint alone is still an organic coating in Category I? reply unit: Guangdong Province, Ecologi
-
Health Insurance Bureau issued a guidance directory: check drug prices, drug companies costs
Time of Update: 2020-09-19
Medical Network September 10, the State Health Insurance Administration issued a directory of administrative law enforcement guidance, involving drug price monitoring, cost investigation and other con
-
Consumption tips for eating wild vegetables: Strange wild vegetables should not be picked reliable channels to buy in moderable quantities
Time of Update: 2020-09-09
Original title: consumption tips for eating wild vegetables: strange wild vegetables do not want to pick reliable channels to buy in moderation the spring acens have reached, the earth warmed up.
Therefore, for unfamiliar wild vegetables, the public should not pick, avoid eating poisonous wild vegetables by mistake!
